| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |